Read original article on New African UK-based pharmaceutical company Stablepharma is preparing for a pivotal Phase 2b clinical trial of ‘SPVX02’, its thermostable version of an existing tetanus-diphtheria vaccine, following the success of a Phase 1 clinical trial. Unlike conventional vaccines which become unusable after a few hours or days out of the fridge, ‘SPVX02’ […]
Read More
Read original article on BMJ.com A tetanus-diphtheria vaccine that can be stored at room temperature has shown promising early results in a development hailed as a potential “game changer” for global health. Maintaining the cold chain for vaccines is a significant challenge in resource poor countries, remote communities, and regions affected by conflict. About half […]
Read More